Fund Holdings — Affinity Asset Advisors, LLC

Total Portfolio Value:
$644.52M
Total Bought:
$109.26M
Total Sold:
$160.79M
Net Transaction:
-$51.53M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Xenon Pharmaceuticals Inc.(XENE)994,2271,144,021+149,794$38.76M$45.04M6.99%+$6.28M
Apogee Therapeutics Inc836,283664,198-172,085$32.91M$39.01M6.05%+$6.11M
Nuvalent Inc200,000337,500+137,500$15.17M$34.53M5.36%+$19.35M
Arcellx Inc
COMMON STOCK
460,000400,000-60,000$25.39M$33.40M5.18%+$8.02M
Alkermes plcSHS(ALKS)650,0001,000,000+350,000$15.66M$27.99M4.34%+$12.32M
Teva Pharmaceutical Industries LimitedADS(TEVA)1,450,0001,400,000-50,000$23.56M$25.23M3.91%+$1.67M
Madrigal Pharmaceuticals, Inc.(MDGL)110,000100,000-10,000$30.82M$21.22M3.29%-$9.60M
Crinetics Pharmaceuticals In515,000400,000-115,000$23.07M$20.44M3.17%-$2.63M
Nurix Therapeutics, Inc.(NRIX)912,000860,399-51,601$19.03M$19.33M3.00%+$299.7K
Vera Therapeutics, Inc.CL A(VERA)375,000435,000+60,000$13.57M$19.23M2.98%+$5.66M
Verona Pharma PlcADS700,000650,000-50,000$10.12M$18.70M2.90%+$8.58M
Autolus Therapeutics plcADS(AUTL)4,300,0004,500,000+200,000$14.96M$16.34M2.53%+$1.37M
Centessa Pharmaceuticals PlcADS1,135,702965,612-170,090$10.26M$15.44M2.40%+$5.18M
Inozyme Pharma Inc2,856,2522,822,318-33,934$12.74M$14.76M2.29%+$2.02M
Spyre Therapeutics, Inc.(SYRE)513,420498,420-15,000$12.07M$14.66M2.27%+$2.59M
Omeros CorpNOTE 5 250 2 1000$8.08M$14.64M2.27%+$6.55M
Kura Oncology, Inc.(KURA)650,000687,785+37,785$13.38M$13.44M2.09%+$55.8K
Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS)000$8.64M$13.05M2.02%+$4.41M
Establishment Labs Holdings Inc.(ESTA)223,407290,447+67,040$10.15M$12.57M1.95%+$2.42M
Viridian Therapeutics, Inc.(VRDN)150,000525,000+375,000$1.95M$11.94M1.85%+$9.99M
Wave Life Sciences, Inc.SHS(WVE)375,0001,400,000+1,025,000$1.87M$11.48M1.78%+$9.61M
Karyopharm Therapeutics IncNOTE 3 000 10 1000$6.30M$9.62M1.49%+$3.32M
Oruka Therapeutics, Inc.(ORKA)0349,836+349,836$0$8.57M1.33%+$8.57M
Rezolute, Inc.(RZLT)1,850,0001,700,000-150,000$7.96M$8.24M1.28%+$290.0K
Merus N V125,000161,741+36,741$7.40M$8.08M1.25%+$684.3K
Astria Therapeutics Inc975,606725,106-250,500$8.88M$7.98M1.24%-$894.6K
BeOne Medicines AGADR(ONC)110,00035,000-75,000$15.69M$7.86M1.22%-$7.84M
Newamsterdam Pharma Company
ORDINARY SHARES
423,155472,390+49,235$8.13M$7.84M1.22%-$287.1K
BridgeBio Pharma, Inc.(BBIO)100,000300,000+200,000$2.53M$7.64M1.19%+$5.11M
Climb Bio, Inc.(CLYM)1,670,6611,500,000-170,661$11.88M$7.63M1.18%-$4.24M
Axsome Therapeutics, Inc.(AXSM)80,00080,0000$6.44M$7.19M1.12%+$749.6K
Erasca, Inc.(ERAS)2,499,4312,499,4310$5.90M$6.82M1.06%+$924.8K
Geron Corporation(GERN)1,500,0001,500,0000$6.36M$6.81M1.06%+$450.0K
Perspective Therapeutics, Inc.(CATX)550,000500,000-50,000$5.48M$6.67M1.04%+$1.19M
Immunovant, Inc.(IMVT)346,088225,000-121,088$9.14M$6.41M1.00%-$2.72M
Arrowhead Pharmaceuticals, Inc.(ARWR)50,000325,000+275,000$1.30M$6.30M0.98%+$5.00M
Vaxcyte, Inc.(PCVX)60,00050,000-10,000$4.53M$5.71M0.89%+$1.18M
Arvinas, Inc.(ARVN)0225,000+225,000$0$5.54M0.86%+$5.54M
Terns Pharmaceuticals Inc0600,000+600,000$0$5.00M0.78%+$5.00M
Springworks Therapeutics Inc69,999147,500+77,501$2.64M$4.73M0.73%+$2.09M
Cullinan Therapeutics, Inc.(CGEM)263,817263,8170$4.60M$4.42M0.69%-$184.7K
Travere Therapeutics, Inc.NOTE 2 250 3 0(TVTX)000$0$4.32M0.67%+$4.32M
Celldex Therapeutics, Inc.(CLDX)475,400125,000-350,400$17.59M$4.25M0.66%-$13.35M
Mineralys Therapeutics, Inc.(MLYS)327,959350,000+22,041$3.84M$4.24M0.66%+$401.4K
Insmed Incorporated(INSM)125,00050,000-75,000$8.38M$3.65M0.57%-$4.72M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
350,000350,0000$3.52M$3.51M0.54%-$10.5K
Nextcure Inc1,687,9552,302,598+614,643$2.68M$3.15M0.49%+$470.7K
Savara Inc.(SVRA)1,546,850700,000-846,850$6.23M$2.97M0.46%-$3.27M
Nkarta, Inc.(NKTX)200,000650,000+450,000$1.18M$2.94M0.46%+$1.76M
Mirum Pharmaceuticals, Inc.(MIRM)155,00075,000-80,000$5.30M$2.92M0.45%-$2.37M
Immatics N.V.SHS(IMTX)300,000250,000-50,000$3.49M$2.85M0.44%-$633.5K
Helix Acquisition Corp IiCL A250,000250,0000$2.56M$2.61M0.41%+$57.5K
Context Therapeutics Inc.(CNTX)1,619,1401,321,153-297,987$3.25M$2.59M0.40%-$656.9K
Inari Med Inc200,00060,000-140,000$9.63M$2.47M0.38%-$7.16M
Roivant Sciences Ltd.SHS(ROIV)351,587201,587-150,000$3.72M$2.33M0.36%-$1.39M
Kezar Life Sciences Inc1,761,7782,511,778+750,000$1.06M$1.94M0.30%+$885.0K
COMPASS Pathways plcADS(CMPS)500,512300,512-200,000$3.02M$1.89M0.29%-$1.13M
Tectonic Therapeutic, Inc.(TECX)58,33158,3310$960.7K$1.77M0.27%+$806.7K
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
202,599212,974+10,375$1.92M$1.49M0.23%-$425.8K
Soleno Therapeutics Inc025,000+25,000$0$1.26M0.20%+$1.26M
Aerovate Therapeutics Inc200,000600,000+400,000$332.0K$1.25M0.19%+$922.0K
Q32 Bio Inc.(QTTB)27,77727,7770$498.6K$1.24M0.19%+$740.8K
Verastem, Inc.(VSTM)0400,000+400,000$0$1.20M0.19%+$1.20M
BioMarin Pharmaceutical Inc.(BMRN)015,000+15,000$0$1.05M0.16%+$1.05M
Zura Bio LimitedCL A(ZURA)223,335223,3350$781.7K$906.7K0.14%+$125.1K
Puma Biotechnology, Inc.(PBYI)250,000250,0000$815.0K$637.5K0.10%-$177.5K
Repare Therapeutics Inc0173,351+173,351$0$596.3K0.09%+$596.3K
Kyverna Therapeutics, Inc.(KYTX)200,000119,900-80,100$1.50M$586.3K0.09%-$913.7K
Adagio Medical Holdings, Inc.(ADGM)0213,235+213,235$0$550.1K0.09%+$550.1K
Immatics N.VW EXP 07 01 202187,204187,2040$484.9K$430.6K0.07%-$54.3K
Avalo Therapeutics, Inc.(AVTX)45,00045,0000$561.1K$425.7K0.07%-$135.4K
Voyager Therapeutics, Inc.(VYGR)051,727+51,727$0$302.6K0.05%+$302.6K
Neurobo Pharmaceuticals In89,22289,2220$431.8K$282.8K0.04%-$149.0K
Genelux Corporation(GNLX)100,000100,0000$195.0K$237.0K0.04%+$42.0K
Whitehawk Therapeutics, Inc.(WHWK)047,019+47,019$0$96.9K0.02%+$96.9K
Promis Neurosciences Inc265,95830,643-235,315$398.9K$38.3K0.01%-$360.6K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)75,00075,0000$4.5K$5.3K0.00%+$727
ADC Therapeutics SASHS(ADCT)474,7440-474,744$1.50M$0—-$1.50M
Alnylam Pharmaceuticals, Inc.NOTE 1 000 9 1(ALNY)000$16.20M$0—-$16.20M
Arca Biopharma Inc72,4840-72,484$277.6K$0—-$277.6K
Arya Sciences Acqu Corp IvCL A133,5000-133,500$1.53M$0—-$1.53M
Black Diamond Therapeutics I650,0000-650,000$3.03M$0—-$3.03M
BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO)000$17.26M$0—-$17.26M
Cerevel Therapeutics Hldng I500,0000-500,000$20.45M$0—-$20.45M
Dyne Therapeutics, Inc.(DYN)100,0000-100,000$3.53M$0—-$3.53M
Elevation Oncology Inc1,468,8250-1,468,825$3.97M$0—-$3.97M
Hillevax Inc265,8590-265,859$3.84M$0—-$3.84M
Iovance Biotherapeutics, Inc.(IOVA)1000-100$802$0—-$802
Mersana Therapeutics Inc767,0000-767,000$1.54M$0—-$1.54M
Morphic Hldg Inc250,5730-250,573$8.54M$0—-$8.54M
Olema Pharmaceuticals, Inc.(OLMA)275,0000-275,000$2.98M$0—-$2.98M
Passage Bio, Inc.(PASG)264,2660-264,266$209.9K$0—-$209.9K
Rapt Therapeutics Inc75,0000-75,000$228.8K$0—-$228.8K
Spdr Ser TrS P BIOTECH
ST STR SP BIOT
37,5500-37,550$3.48M$0—-$3.48M
Tango Therapeutics, Inc.(TNGX)150,2740-150,274$1.29M$0—-$1.29M
Vir Biotechnology, Inc.(VIR)200,0000-200,000$1.78M$0—-$1.78M
Zymeworks Inc.(ZYME)191,1270-191,127$1.63M$0—-$1.63M
Page 1 of 1
Affinity Asset Advisors, LLC — 13F Holdings — Q3 2024 | TickerTrail